Page last updated: 2024-10-24

chelerythrine and Diabetic Neuropathies

chelerythrine has been researched along with Diabetic Neuropathies in 1 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cameron, NE1
Cotter, MA1
Jack, AM1
Basso, MD1
Hohman, TC1

Other Studies

1 other study available for chelerythrine and Diabetic Neuropathies

ArticleYear
Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.
    Diabetologia, 1999, Volume: 42, Issue:9

    Topics: Alkaloids; Animals; Benzophenanthridines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; En

1999